Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

The Faces of Luminex: Yetzielisse Urgelles, Graphic Design

Whether it’s through our website, social media channels, or a conference booth, if you’ve seen Luminex content lately, then you’re already familiar with our talented creative services team. Today, we’re shining the spotlight on Yetzielisse Urgelles, a gifted graphic designer who joined our team in early 2018 after completing her BFA in graphic and web design at The Art Institute of Austin.

Continue Reading >

xMAP® Technology Overview

 
Video Thumbnail  Clinical Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.  Read More Research & Applied Markets Our xMAP® Technology and its flexibl

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


When she isn't creating graphics for our products & social media, Yetzie draws inspiration from the darker side of… https://t.co/10VnT55549
h J R

Latest News

December 6th
Luminex Corporation Declares Fourth Quarter Cash Dividend

4 November
Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

25 October
Luminex Corporation To Release Third Quarter 2019 Results After Market Close On
November 4, 2019

26 September
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019

3 September
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

Events

FIS
11-14 November
Edinburgh, UK


flowcytometryUK 2019
21 November
Cambridge, UK